{
    "componentChunkName": "component---src-containers-call-js",
    "path": "/e/nasdaq/s/vrna/y/2021/q/q1",
    "result": {"pageContext":{"event":{"conference_date":"2021-04-29T09:00:00-04:00","quarter":"q1","transcript":null,"transcript_preview":"7f6d785a-f2c8-4d5a-8ea2-ee01b73c410d.json","year":"2021","audio_file":null},"transcript":{"version":2,"items":null,"speaker_groups":[{"endIndex":0,"speaker":"spk_0","startIndex":0,"start_times":[0],"words":["Welcome"]},{"endIndex":239,"speaker":"spk_1","startIndex":1,"start_times":[1.24,1.39,1.83,2.74,3.17,3.82,4.07,4.32,4.62,5.31,5.85,6.36,6.52,7.03,7.58,8.12,9.04,9.23,9.43,9.81,10.09,10.86,11.04,11.13,11.21,11.58,11.84,14.04,14.43,14.63,15.11,15.27,15.48,15.83,16.38,16.5,16.85,17.22,17.71,17.86,18.31,18.79,18.93,19.07,19.31,19.76,20.01,20.24,20.49,20.83,22.08,22.5,23.34,23.47,23.81,23.99,24.15,24.5,24.59,24.69,25.15,25.67,26.26,26.45,26.53,26.94,27.63,28.79,29.37,29.84,30.49,30.78,32.34,32.6,32.7,33.14,33.31,33.48,33.61,33.96,34.08,34.23,34.5,34.89,35.23,35.71,35.95,36.04,36.56,36.9,38.54,39.18,39.46,40.17,40.45,40.87,41.2,42.44,42.67,42.94,43.27,44.54,44.72,45.01,45.18,45.8,46.31,47.94,48.1,48.61,48.74,49.24,49.85,50.04,50.82,50.95,51.36,51.75,51.96,52.42,52.87,53.83,54,54.23,54.67,55.56,55.72,55.87,56.29,56.51,56.91,57.49,58.25,58.45,59.54,59.6,59.74,60.36,60.99,61.23,61.36,62.26,62.84,62.98,63.49,63.62,63.81,64.07,64.38,65.44,66.59,66.97,67.6,67.75,68.3,68.42,69.28,70.54,70.82,70.91,71.59,72.43,72.93,73.46,73.66,74.15,74.28,74.39,74.85,75.51,75.69,75.77,76.5,76.7,76.82,78.14,78.38,78.71,78.96,79.27,80.21,80.79,81.84,82.49,82.79,83.01,83.13,83.52,83.7,83.92,84.42,85.44,85.66,85.75,86.11,86.29,86.57,86.64,87.18,87.46,87.73,88.03,91.04,91.21,91.49,91.8,91.88,91.98,93.04,93.19,93.76,94.03,94.72,94.84,95.02,95.56,95.94,96.07,96.71,97.27,97.75,97.96,98.24,98.36],"words":["the","Verona","Farmers","fourth","quarter","and","year","and","2020","financial","results","and","operating","highlights","conference","call","at","this","time.","All","participants","are","in","a","listen","only","no","Earlier","this","morning","for","a","farmer","issued","a","press","release","announcing","its","financial","results","for","the","three","months","and","full","year","ended","December","31","2020.","A","copy","can","be","found","in","the","investor","relations","tab","on","the","corporate","website","www","dot","Verona","pharma","dot","com.","Before","we","begin,","I'd","like","to","remind","you","that","during","today's","call","statements","about","the","company's","future","expectations,","plans","and","prospects","are","forward","looking","statements.","These","forward","looking","statements","are","based","on","management's","current","expectations.","These","statements","are","neither","promises","nor","guarantees","and","involve","known","and","unknown","risks,","uncertainties","and","other","important","factors","that","may","cause","our","actual","results,","performance","or","achievements","to","be","materially","different","from","our","expectations","expressed","or","implied","by","the","forward","looking","statements,","Including","without","limitation","the","impact","of","COVID-19","pandemic","on","the","status","recruitment,","timing","results","and","costs","of","our","clinical","trials","and","the","continuity","of","our","business.","Any","such","forward","looking","statements","represent","management","estimates","as","of","the","date","of","this","conference","call.","While","the","company","may","elect","to","update","such","forward","looking","statements","at","some","point","in","the","future,","it","disclaims","any","obligation","to","do","so","even","if","subsequent","events","cause","it's","views","to","change."]},{"endIndex":241,"speaker":"spk_0","startIndex":240,"start_times":[99.57,99.95],"words":["As","A"]},{"endIndex":277,"speaker":"spk_1","startIndex":242,"start_times":[99.99,100.45,100.65,100.88,100.98,101.16,101.71,101.92,102.07,102.42,102.98,103.12,103.45,104.54,104.9,105.14,105.31,105.4,105.62,105.71,106.4,106.67,106.81,107.39,107.93,108.37,109.4,110.01,110.61,111.26,111.66,111.85],"words":["reminder,","this","call","is","being","recorded","and","will","remain","available","for","90","days.","I'd","now","like","to","turn","the","conference","over","to","Dr","David","Zucker","Zaccardelli","Chief","executive","officer.","Please","go","ahead."]},{"endIndex":730,"speaker":"spk_0","startIndex":278,"start_times":[114.44,114.74,114.92,115.17,115.53,116.01,116.16,116.56,117.54,117.87,117.99,118.53,118.84,119.68,120.02,120.32,120.85,122.04,122.35,122.75,123.35,123.74,124.09,124.5,125.64,125.82,126.25,126.82,127.03,127.28,127.73,127.85,129.44,129.63,129.88,130.19,130.31,131.13,131.32,131.39,132.17,132.33,132.42,132.83,133.16,133.3,133.72,134.84,135.15,135.26,135.53,135.7,135.96,136.63,137.03,137.69,138.29,138.47,138.76,138.86,139.26,139.62,140.38,140.64,140.86,141.32,141.73,142.07,142.3,143.07,143.53,143.9,144.38,144.65,145.53,145.71,145.84,146.86,148.74,148.9,149.5,150.01,151.24,151.53,152.38,152.65,153.15,153.64,154.22,154.53,154.71,155.28,155.68,155.9,156.35,156.52,157.09,157.45,158.07,158.62,158.95,159.86,160.6,160.95,161.06,161.66,162.74,162.95,164.14,164.49,164.99,165.67,166.31,166.87,166.99,167.22,167.77,167.94,168.95,169.31,169.82,169.97,170.35,170.47,170.74,171.94,172.12,172.44,172.78,173.31,173.57,174.13,174.3,174.65,174.84,176.44,176.67,176.78,177.26,177.43,177.88,178.31,178.92,179.16,179.31,179.64,179.92,180.4,180.64,180.78,181.09,181.26,181.63,181.82,182.51,182.87,183.17,183.76,184.28,184.48,184.65,184.84,185.07,185.29,185.4,185.52,186.44,186.62,188.04,188.25,188.39,189.1,189.43,190.03,190.27,190.35,190.71,190.94,191.94,192.14,192.26,192.45,192.73,193.01,193.12,193.35,194.64,194.85,195.06,195.43,195.91,196.52,197.74,198.01,198.14,198.94,199.28,200.04,200.14,200.83,201.03,201.16,201.62,202.44,202.93,203.56,204.1,204.6,204.87,205.04,205.59,206.64,206.84,207.08,207.51,207.92,208.23,208.71,209.25,209.44,210.94,211.21,211.93,212.18,212.92,213.13,213.63,214,214.26,214.91,215.07,215.29,216.14,216.53,216.72,217.23,218.01,219.21,219.43,220.94,221.24,221.9,222.1,222.53,222.65,223.05,223.25,223.46,223.54,223.61,223.96,224.05,224.9,225.51,225.65,226.31,226.99,227.18,229.04,229.31,229.45,229.73,229.82,230.85,231.05,231.19,231.51,231.94,232.32,232.53,232.73,233.12,234.04,234.24,234.43,234.7,235.17,235.69,237.64,238,238.21,238.84,239.06,239.49,239.92,240.84,241.08,241.19,241.9,242.33,242.75,242.93,243.13,243.55,243.78,244.22,244.43,245.04,245.67,245.78,246.18,247.03,247.21,247.65,247.79,248.23,248.88,250.34,250.72,251.18,251.65,251.82,253.14,253.43,253.53,254.06,254.54,254.66,255.1,255.31,256.34,256.58,256.9,257.31,258.01,258.08,258.79,259.01,259.65,260.36,260.82,261.35,262.44,262.64,263.07,263.48,264.12,264.68,264.88,265.12,266.04,266.32,266.56,266.65,266.85,268.04,268.74,269.12,269.52,269.83,270.17,270.62,271.06,271.15,271.95,272.5,272.85,273.08,273.19,274.54,274.66,275.22,275.54,275.82,275.95,276.64,277.34,277.67,278.76,279.41,279.54,280.12,280.81,281.64,281.97,282.39,282.86,283.74,284.14,284.73,285.23,286.42,286.56,286.88,287.84,288.09,288.51,289.19,289.35,289.77,290.07,290.45,290.6,291.94,292.24,292.49,293.03,293.39,293.67,293.96,294.07,294.41,294.57,295.04,295.48,296.35,296.66,296.77,297.15,297.24,299.04,299.24,299.33,299.56],"words":["Thank","you","and","welcome","everyone","to","today's","call","with","me","today","are","Marcon,","our","chief","financial","officer,","DR","Kathy","Ricard,","our","chief","medical","officer","and","Christopher","martin.","Our","vice","president","of","commercial","The","fourth","quarter","of","2020","with","the","continuation","of","a","pivotal","year","for","Verona","Pharma.","During","the","year","we","made","substantial","clinical","progress,","advancing","our","first","in","class","product","candidate","and","stiff","entrance","into","Phase","three","trials","and","raised","$200","million","dollars","in","an","oversubscribed","financing.","Our","2020","highlights","included","in","january,","we","reported","positive","data","from","a","Phase","two","B.","Trial","with","nebulas","entice","entrance","added","onto","bronchodilator","therapy","for","the","maintenance","treatment","of","COPD.","Hence","invention,","demonstrated","significant","improvements","in","lung","function","and","importantly","in","symptoms","and","quality","of","life","measurement.","The","data","also","supported","dose","selection","for","Phase","three","trials.","And","in","March","we","reported","positive","data","from","the","single","dose","part","of","a","phase","two","trial","with","pressurised","metered","dose","inhaler","or","P.","M.","D.","I.","And","see","if","entrance","in","COPD.","And","in","May","we","received","end","of","Phase","two","guidance","from","the","U.","S.","Food","and","Drug","Administration","On","our","face","three","enhanced","program.","And","in","July","we","recapitalize","the","company","with","a","200","million","dollar","private","placement","allowing","us","to","initiate","enrollment","In","the","pivotal","Phase","three","enhanced","trials","in","September","and","finally","we","initiated","a","pilot","study","with","PMG","and","stiff","entrance","In.","US.","patients.","Hospitalists","COVID-19","in","September.","We","executed","on","all","our","goals","set","out","at","the","beginning","of","2020.","Despite","the","unexpected","challenges","of","COVID-19.","As","we","turn","to","2021,","we","have","already","announced","data","from","one","clinical","trial","and","have","three","additional","trials","underway.","Earlier","this","month,","we","announced","positive","results","from","the","multiple","dose","part","of","our","phase","two","trial","with","PMD","formulation","of","NCF","entrance","in","moderate","to","severe","COPD","patients","empty","Fenton","delivered","by","PMG","met","the","primary","endpoint","of","improved","lung","function","with","anti","benton","demonstrating","a","clinically","and","statistically","significant","dose","dependent","improvement","in","peak","forced","exploratory","volume","in","one","second","for","f.","E.","V","1/4","hours","post","dose","with","NC","Fenton","compared","to","placebo","after","seven","days","of","treatment.","In","addition,","anti","french","and","demonstrated","clinically","and","meaningful,","meaningful","and","statistical,","significant","improvements","in","trough","FDD","one","and","average","FTV","1/4","and","12","hours","with","safety,","intolerable.","Itty","again,","very","similar","to","placebo.","These","data","support","twice","daily","dose","of","events","if","entrance","via","PMG","for","the","treatment","of","COPD","in","the","near","term."]}],"transcripts":null,"speaker_labels":null},"buildVersion":"598","companyName":"Verona Pharma plc","exchange":"NASDAQ","isApproved":true,"optOut":null,"isTranscriptPreview":null,"securityName":"Verona Pharma plc","symbol":"VRNA","site":{"siteMetadata":{"title":"EarningsCall","buildVersion":"598","buildTime":"2022-03-03T07:06:57.252Z","commitId":"52a5b110","stage":"prod"}}}},
    "staticQueryHashes": []}